These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
302 related articles for article (PubMed ID: 3807366)
1. Fertility control in women: results with RU 486 by the end of 1985. Baulieu E J Steroid Biochem; 1986 Nov; 25(5B):847-51. PubMed ID: 3807366 [TBL] [Abstract][Full Text] [Related]
2. Antiprogesterone activity of RU 486 and its contragestive and other applications. Baulieu EE; Ulmann A Hum Reprod; 1986 Feb; 1(2):107-10. PubMed ID: 3031127 [TBL] [Abstract][Full Text] [Related]
3. The use of anti-progesterones as a medical IUD. Nieman LK; Loriaux DL Baillieres Clin Obstet Gynaecol; 1988 Sep; 2(3):609-16. PubMed ID: 3233821 [TBL] [Abstract][Full Text] [Related]
4. The antiprogesterone steroid RU 486: a short pharmacological and clinical review, with emphasis on the interruption of pregnancy. Garfield RE; Baulieu EE Baillieres Clin Endocrinol Metab; 1987 Feb; 1(1):207-21. PubMed ID: 3297023 [TBL] [Abstract][Full Text] [Related]
6. A novel approach to human fertility control: contragestion by the anti-progesterone RU 486. Baulieu EE Eur J Obstet Gynecol Reprod Biol; 1988 Jun; 28(2):125-9. PubMed ID: 3402651 [TBL] [Abstract][Full Text] [Related]
7. Fertility control with RU 486. Ulmann A; Dubois C; Philibert D Horm Res; 1987; 28(2-4):274-8. PubMed ID: 3331378 [TBL] [Abstract][Full Text] [Related]
8. Mifepristone (RU486) alone or in combination with a prostaglandin analogue for termination of early pregnancy: a review. Avrech OM; Golan A; Weinraub Z; Bukovsky I; Caspi E Fertil Steril; 1991 Sep; 56(3):385-93. PubMed ID: 1894013 [TBL] [Abstract][Full Text] [Related]
9. Anti-progesterones for the interruption of pregnancy. Bygdeman M; Van Look PF Baillieres Clin Obstet Gynaecol; 1988 Sep; 2(3):617-29. PubMed ID: 3069265 [TBL] [Abstract][Full Text] [Related]
10. Antiprogestin drugs: research and clinical use in Sweden. Bygdeman M; Swahn ML Law Med Health Care; 1992; 20(3):157-60. PubMed ID: 1434756 [TBL] [Abstract][Full Text] [Related]
11. Antifertility actions of the progesterone antagonist RU 486 include direct inhibition of placental hormone secretion. Das C; Catt KJ Lancet; 1987 Sep; 2(8559):599-601. PubMed ID: 2887889 [TBL] [Abstract][Full Text] [Related]
12. Effect of oral prostaglandin E2 on uterine contractility and outcome of treatment in women receiving RU 486 (mifepristone) for termination of early pregnancy. Swahn ML; Ugocsai G; Bygdeman M; Kovacs L; Belsey EM; Van Look PF Hum Reprod; 1989 Jan; 4(1):21-8. PubMed ID: 2651472 [TBL] [Abstract][Full Text] [Related]
14. Uses of RU 486 for contragestion: an update. Ulmann A Contraception; 1987; 36 Suppl():27-31. PubMed ID: 2445523 [TBL] [Abstract][Full Text] [Related]
15. [Clinical use of RU 486: control of the menstrual cycle and effect on the hypophyseal-adrenal axis]. Gaillard RC; Herrmann W Ann Endocrinol (Paris); 1983; 44(5):345-6. PubMed ID: 6675522 [TBL] [Abstract][Full Text] [Related]
16. Termination of early pregnancy by a single dose of mifepristone (RU 486), a progesterone antagonist. Maria B; Stampf F; Goepp A; Ulmann A Eur J Obstet Gynecol Reprod Biol; 1988 Jul; 28(3):249-55. PubMed ID: 3208966 [TBL] [Abstract][Full Text] [Related]
17. Mifegyne (mifepristone), a new antiprogestagen with potential therapeutic use in human fertility control. Couzinet B; Schaison G Drugs; 1988 Mar; 35(3):187-91. PubMed ID: 3286211 [TBL] [Abstract][Full Text] [Related]